# Long-Term Safety and Efficacy of Moxifloxacin in Bronchiectasis Patients

> **NCT07274020** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 140 (estimated)

## Conditions studied

- Bronchiectasis, Non-Cystic Fibrosis

## Interventions

- **DRUG:** Intermittent Moxifloxacin + Standard Care
- **OTHER:** Standard Care (in control arm)

## Key facts

- **NCT ID:** NCT07274020
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07274020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07274020, "Long-Term Safety and Efficacy of Moxifloxacin in Bronchiectasis Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07274020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*